• Christina Bachmeier, PharmD, BCOP, Moffitt Cancer Center
  • Stephen Badylak, DVM, PhD, MD, University of Pittsburgh
  • John Barrett, MD, George Washington University Hospital
  • Peter Beemiller, Berkeley Lights Inc.
  • Valkal Bhatt, PharmD, BCOP, BCPS, Memorial Sloan Kettering Cancer Center
  • Catherine Bollard, MBChB, MD, Children’s National Medical Center
  • Dori Borjesson, BA, DVM, MPVM, PhD, UC Davis School of Veterinary Medicine
  • Lynne Boxer, DVM, FDA
  • Lisa Butterfield, PhD, University of Pittsburgh
  • Lizette Caballero, BS, MT(ASCP), UCSF Blood and Marrow Transplant Lab
  • Mitch Cairo, MD, New York Medical College
  • Angelo Cardoso, MD, PhD, City of Hope
  • Marian Dam, DNP, APRN, Moffitt Cancer Center
  • Hema Dave, MD, MPH, Children’s National Medical Center
  • Robert Deans, PhD, BlueRock Therapeutics
  • Steven Devine, MD, CIBMTR
  • Allan Dietz, PhD, Mayo Clinic
  • Paul Eldridge, PhD, UNC Lineberger Comprehensive Cancer Center
  • Yong Fan, MD, A2Z Reg Solutions
  • William Faubion, MD, Mayo Clinic
  • Jacques Galipeau, MD, University of Wisconsin – Madison
  • Rebecca Gardner, MD, Seattle Children’s Hospital
  • Saar Gill, MD, PhD, University of Pennsylvania
  • Michael Grimley, MD, Cincinnati Children’s Hospital Medical Center
  • Kurt Gunter, MD, Cell Medica Inc.
  • Patrick Hanley, PhD, Children’s National Health System
  • Mo Heidaran, PhD, PAREXEL
  • Peiman Hematti, MD, University of Wisconsin-Madison
  • Andrew Hoffman, DVM, DVSc, DACVIM, University of Pennsylvania
  • Laertis Ikonomou, PhD, Boston University
  • Adnan Jaigirdar, MD, FDA
  • Timothy Kamp, MD, PhD, University of Wisconsin-Madison
  • Dan Kaufman, MD, PhD, University of California San Diego
  • Aisha Khan, MS, MBA, University of Miami
  • Ashwani Khurana, PhD, Mayo Clinic Rochester
  • Ajay Kuriyan, MD, MS, University of Rochester Medical Center
  • Bruce Levine, PhD, University of Pennsylvania
  • James Lim, PhD, Xcell Biosciences Inc.
  • Peter Marks, MD, PhD, FDA
  • Kristin Matthews, PhD, Rice University’s Baker Institute for Public Policy
  • Lauralyn McIntyre, MD, MHSc, FRCPC, Ottawa Hospital Research Institute
  • Jeffrey Medin, PhD, Medical College of Wisconsin
  • Cynthia Molina, Triumvira
  • William Murphy, PhD, University of Wisconsin-Madison
  • Sarah Nikiforow, MD, PhD, Dana-Farber Cancer Institute
  • Lynn O’Donnell, PhD, Ohio State University, James Cancer Hospital Columbus
  • Paul Orchard, MD, University of Minnesota
  • Kyla Ortved, DVM, PhD, University of Pennsylvania
  • Anand Padmanabhan, MD, PhD, Blood Center of Wisconsin
  • Stephanie Protze, PhD, University of Toronto
  • Denis-Claude Roy, MD, FRCPC, Hopital Maisonneuve-Rosemont
  • Marianna Sabatino, MD, Arcellx
  • Krishanu Saha, PhD, University of Wisconsin-Madison
  • Joseph Schwartz, MD, PhD, Columbia University
  • Don Siegel, MD, PhD, University of Pennsylvania
  • Donna Skerrett, MD, MS, Mesoblast
  • Etienne Sokal, MD, PhD, Promethera Université Catholique de Louvain
  • Karl Stasko, BSc, MPH, Dana Farber Cancer Institute
  • Olive Sturtevant, MSc, Dana Farber Cancer Institute
  • Julia Thebiay, IMPACT, Mayo Clinic Rochester
  • Erika Trauzzi, PhD, MBA, Berkeley Lights
  • Gil Van Bokkelen, PhD, Athersys
  • Sumithira Vasu, MBBS, Comprehensive Cancer Center, Ohio State University
  • Tracey Webb, DVM, PhD, Colorado State University
  • Daniel Weiss, MD, PhD, University of Vermont
  • Mervin Yoder, MA, MD, Indiana University School of Medicine
  • Jiwen Zhang, PhD, PassageBio